Global Fish Vaccine Market, by Vaccine Type (Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccines), by Indication (Furunculosis, Vibriosis, Yersiniosis, Enteric septicaemia, and Others), by Route of Administration (Injection, Immersion, Spray and Oral), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 249.20 Million in 2022, and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).

Market players are involved in product launches, which is expected to drive the market growth over the forecast period. For instance, in 2018, HIPRA, a multinational pharmaceutical and biotechnology company, launched injectable vaccine, ICTHIOVAC VR/PD, against vibriosis and pasteurellosis in sea bass. The company launched ICTHIOVAC VR/PD for sea bream and sea bass in Spain, Italy, Portugal, France, Tunisia, and others.

Increasing government initiatives to increase aquaculture is expected to boost the growth of the global fish vaccine market over the forecast period. For instance, in April 2022, European Union launched a project along with the grant of US$ 269,670 in order to increase the size of Morocco’s aquaculture sector. The project is being run in partnership with France’s Ministry of Agriculture and Morocco’s National Agency for the Development of Aquaculture (ANDA).

Global Fish Vaccine Market - Impact of Coronavirus (COVID – 19) Pandemic

The COVID-19 pandemic has affected several markets across the globe. The COVID-19 pandemic has affected the demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and by impacting firms and markets financially.

The impact of COVID-19 on the global fish vaccine market was also significant, owing to a decrease in fisheries production. For instance, according to the Springer journal in August 2021, the COVID-19 had a tremendously large impact on the aquaculture and seafood industries, and the people who depend only on seafood had to endure a lot of hardships. Additionally, the food supply chain was hampered due to various precautions taken in an effort to combat the pandemic's negative effects. The difficulties generated by the strained purchase of inputs as a result of the distorted exports had a significant negative impact on the aquaculture industry.

Browse 35 Market Data Tables and 39 Figures spread through 177 Pages and in-depth TOC on the Global Fish Vaccine Market, by Vaccine Type (Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccines), by Indication (Furunculosis, Vibriosis, Yersiniosis, Enteric septicaemia, and Others), by Route of Administration (Injection, Immersion, Spray, and Oral), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Global Fish Vaccine Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/fish-vaccine-market-5184

Key Takeaways of the Global Fish Vaccine Market:

  • Global fish vaccine market is expected to exhibit a CAGR of 6.5% over the forecast period (2022-2030). North America is expected to account for a major market share over the forecast period (2022-2030), owing to increasing initiatives by government to increase fish and seafood production. For instance, in February 2022, the U.S. Department of Agriculture (USDA) announced a US$ 50 million grant investment to support seafood processors, processing facilities, and processing vessels through the Seafood Processors Pandemic Response and Safety Block Grant Program (SPRS).
  • Some of the major players operating in the global fish vaccine market include HIPRA, VETERQUIMICA SA, Ictyogroup, Kyoto Biken Laboratories, Inc., Vaxxinova International BV, Barramundi Group, Merck & Co., Inc., Zoetis Inc., KBNP, INC., Aqua Vet S.A., and NISSEIKEN CO., LTD

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo